Skip to content

Effect of Unani Formualtions in Qooba

Comparative Clinical Evaluation of Unani Formulations With Special Reference to Mizaj in the Treatment of Qooba [Dermatophytosis] - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065285
Enrollment
104
Registered
2024-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B35- Dermatophytosis

Interventions

Intervention1: Joshanda Chiraita and Absinthium oil based cream: Joshanda Chiraita given orally 5-7 gm twice a day for 28 days Absinthium oil based cream apply locally twice a day for 28 days Control

Sponsors

Department Amraze jild wa zohrawiya Ajaml khan tibbiya college Aligarh Muslim University ALIGARH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Tinea [Quba] attending OPD of AKTC hospital confirmed by Direct microscopy . Patients of either gender . Age group 15-60 years . Patients who have agreed to sign the informed consent form , comply with the study procedure, and availability for regular follow up during the protocol .

Exclusion criteria

Exclusion criteria: Patients of Tinea [Quba] attending OPD of AKTC hospital confirmed by Direct microscopy . Patients of either gender . Age group 15-60 years . Patients who have agreed to sign the informed consent form , comply with the study procedure, and availability for regular follow up during the protocol .

Design outcomes

Primary

MeasureTime frame
Outcomes of the treatment will be assessed by three parameters. Clinical Cure. Mycological Cure[ negative KOH Preparation] . Photography of the lesions . Timepoint: Assesment of all parameters at initiation of the study 0 day, 7 day, 14, 21 and 28 day of the study

Secondary

MeasureTime frame
Itching Erythematous areas with elevated margins. Erythematous papules. Vesicles around a variable pigmented patch. Scaling Timepoint: Assessment of all parameters at initiation of the study 0 day 7 day, 14 ,21 ,28 day of the study

Countries

India

Contacts

Public ContactMubashira Karimi

Ajmal Khan Tibbiya College

s.aleem786@gmail.com9897249995

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026